Prostate Cancer

Showing the single result

  • Oxnard

    Prostate Cancer Study

    This clinical trial is being conducted to demonstrate the efficacy of a study treatment for metastatic castration-resistant prostate cancer in patients who have failed prior treatment with at least one androgen receptor targeting agent as measured by radiographic progression-free survival.   Criteria & Qualifications: • Must be 18 years to 100 years old
    • Histological or cytologic proof of adenocarcinoma of the prostate
    • Male   Compensation: Contact us for more information

    Read more